Goldman Sachs
EPIX

Goldman Sachs’s ESSA Pharma EPIX Stock Holding History

Goldman Sachs’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,531
Closed -$45K – 6051
2022
Q3 		$45K Buy
24,531
+12,792
+109% +$33.7K ﹤0.01% 5813
2022
Q2 		$37K Sell
11,739
-65,427
-85% -$366K ﹤0.01% 6086
2022
Q1 		$477K Sell
77,166
-17,224
-18% -$151K ﹤0.01% 5346
2021
Q4 		$1.34M Sell
94,390
-27,211
-22% -$303K ﹤0.01% 4598
2021
Q3 		$973K Buy
121,601
+54,827
+82% +$872K ﹤0.01% 4768
2021
Q2 		$1.91M Buy
66,774
+25,783
+63% +$749K ﹤0.01% 4245
2021
Q1 		$1.19M Buy
40,991
+30,707
+299% +$714K ﹤0.01% 4462
2020
Q4 		$123K Buy
+10,284
New +$72.4K ﹤0.01% 5254

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ABG
Ally Bridge Group New York $101M AUM 249.88% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return